全文获取类型
收费全文 | 248篇 |
免费 | 13篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 7篇 |
妇产科学 | 4篇 |
基础医学 | 47篇 |
临床医学 | 23篇 |
内科学 | 54篇 |
皮肤病学 | 6篇 |
神经病学 | 16篇 |
特种医学 | 4篇 |
外科学 | 14篇 |
预防医学 | 23篇 |
眼科学 | 7篇 |
药学 | 16篇 |
中国医学 | 1篇 |
肿瘤学 | 40篇 |
出版年
2023年 | 2篇 |
2022年 | 5篇 |
2021年 | 6篇 |
2020年 | 6篇 |
2019年 | 4篇 |
2018年 | 9篇 |
2017年 | 5篇 |
2016年 | 6篇 |
2015年 | 9篇 |
2014年 | 19篇 |
2013年 | 13篇 |
2012年 | 28篇 |
2011年 | 16篇 |
2010年 | 20篇 |
2009年 | 16篇 |
2008年 | 22篇 |
2007年 | 12篇 |
2006年 | 11篇 |
2005年 | 10篇 |
2004年 | 10篇 |
2003年 | 8篇 |
2002年 | 10篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1997年 | 3篇 |
1995年 | 2篇 |
1993年 | 2篇 |
1991年 | 1篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1985年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有263条查询结果,搜索用时 15 毫秒
61.
Hiart Maortua Cristina Martínez-Bouzas Ainhoa García-Ribes María-Jesus Martínez Encarna Guillen María-Rosario Domingo María-Teresa Calvo Miriam Guitart Elisabeth Gabau María-Pilar Botella Blanca Gener Izaskun Rubio María-Asunción López-Aríztegui María-Isabel Tejada 《The Journal of molecular diagnostics : JMD》2013,15(5):723-729
62.
Encarna B Gómez-García Ton Ambergen Marinus J Blok Arthur van den Wijngaard 《Journal of clinical oncology》2005,23(10):2185-2190
PURPOSE: To obtain and compare the probabilities of finding a mutation in the BRCA1 or BRCA2 genes, the clinical features, and the family history among patients with an unclassified variant (UV) and those with a pathogenic mutation. PATIENTS AND METHODS: The study included 70 patients: 24 with a UV (BRCA1, n = 4; BRCA2, n = 19; both, n = 1), and 46 with a mutation (BRCA1, n = 32; BRCA2, n = 14). Two of the UVs were novel variants; the rest had been reported previously as UVs. Probabilities of finding a mutation were retrospectively obtained using BRCAPRO and Myriad II programs. RESULTS: The probability to detect a mutation was significantly lower in the group of patients with a UV than in those with a mutation (BRCAPRO [mean +/- standard deviation], 0.297 +/- 0.312 v 0.627 +/- 0.315, P = .001; and Myriad II, 0.124 +/- 0.090 v 0.283 +/- 0.176, P = .001, respectively). Independent predictive factors of finding either a UV or a mutation were number of affected relatives (2.9 +/- 1.4 v 4.0 +/- 1.9; P = .039) and number of tumors among relatives (3.3 +/- 1.4 v 4.4 +/- 1.8; P = .031), respectively. CONCLUSION: The combined data about the predictive models show significant differences between both groups. Individual probabilities can be regarded as a help to guide the clinical management of patients with a UV in those genes. However, a definitive conclusion about the pathogenicity of a UV can not be obtained from the clinical features alone, but only in combination with biochemical and epidemiologic data. 相似文献
63.
Esteban Jarque E Expósito Mozas L Olalla Martín M Alvarez Alvarez I 《Revista de enfermería (Barcelona, Spain)》2002,25(9):66-70
This is a novel technique which provides information about all the happenings going on in the brain and which helps to better interpret the complete physiologic pathology of a patient suffering from serious cranial encephalitic trauma. The authors describe how to put this technique into practice, what materials are necessary to do so, and what conclusions may be obtained from biochemical analysis. 相似文献
64.
65.
Mohedano Mohedano N Sánchez Rovira P Lozano Barriuso A Fernandez Morales M Medina Magan B Jaen Morago A Porras Quintela I Dueñas Garcia R Fernandez Flores E Moreno Moreno MA 《American journal of clinical oncology》2003,26(4):363-365
A phase II study was conducted to evaluate the safety and efficacy of the combination GIP (gemcitabine, ifosfamide, and cisplatin) for the treatment of patients with advanced non-small-cell lung cancer (NSCLC). Thirty patients with stage III B/IV NSCLC were treated with a combination of GIP. Patients received gemcitabine 1,000 mg/m2 administered intravenously on days 1 and 8, ifosfamide 3,500 mg/m2 on day 2, and cisplatin 80 mg/m2 on day 2, repeated every 21 days. Two of the 30 patients (7%) showed a complete response and 14 patients (46%) showed a partial response. The overall response rate was 53%. The estimated median survival for all patients was 60 weeks. All patients enrolled onto the study were eligible for toxicity assessment. Toxicities were treatable and included World Health Organization grade III or IV leukopenia (29%), thrombocytopenia (18%), anemia (7%) and nausea, and vomiting (6%). Febrile neutropenia occurred in 3 of 30 patients. There were no treatment-related deaths. The combination therapy of GIP is active, well tolerated, and easy to administer on an outpatient basis in advanced NSCLC. 相似文献
66.
Nuria Acero Teresa Ortega Victoria Villagrasa Gemma Leon Dolores Muñoz-Mingarro Encarna Castillo M. Eugenia González-Rosende Silvia Borrás Jose Luis Rios Francisco Bosch-Morell Isabel Martínez-Solís 《Phytotherapy research : PTR》2023,37(3):1176-1211
The incidence and prevalence of age-related neurodegenerative dementias have been increasing. There is no curative therapy and conventional drug treatment can cause problems for patients. Medicinal plants traditionally used for problems associated with ageing are emerging as a therapeutic resource. The main aim is to give a proposal for use and future research based on scientific knowledge and tradition. A literature search was conducted in several searchable databases. The keywords used were related to neurodegenerative dementias, ageing and medicinal plants. Boolean operators and filters were used to focus the search. As a result, there is current clinical and preclinical scientific information on 49 species used in traditional medicine for ageing-related problems, including neurodegenerative dementias. There are preclinical and clinical scientific evidences on their properties against protein aggregates in the central nervous system and their effects on neuroinflammation, apoptosis dysregulation, mitochondrial dysfunction, gabaergic, glutamatergic and dopaminergic systems alterations, monoamine oxidase alterations, serotonin depletion and oestrogenic protection. In conclusion, the potential therapeutic effect of the different medicinal plants depends on the type of neurodegenerative dementia and its stage of development, but more clinical and preclinical research is needed to find better, safer and more effective treatments. 相似文献
67.
Emilio Alba Miguel Martín Manuel Ramos Encarna Adrover Ana Balil Carlos Jara Agustí Barnadas Antonio Fernández-Aramburo Pedro Sánchez-Rovira Margarita Amenedo Antonio Casado 《Journal of clinical oncology》2004,22(13):2587-2593
PURPOSE: This randomized, multicenter, phase III trial evaluated whether sequential doxorubicin and docetaxel (A-->T) reduced hematological toxicity, especially febrile neutropenia, compared with concomitant (AT) administration as first-line chemotherapy in metastatic breast cancer (MBC). PATIENTS AND METHODS: One hundred forty-four patients were randomly assigned to receive three cycles of doxorubicin 75 mg/m(2) every 21 days followed by three cycles of docetaxel 100 mg/m(2), every 21 days (A-->T) or six cycles of the combination doxorubicin 50 mg/m(2) and docetaxel 75 mg/m(2) (AT) every 21 days. Patients previously treated with anthracyclines received two cycles of doxorubicin followed by four cycles of docetaxel (A-->T), or three cycles of AT followed by three cycles of docetaxel 100 mg/m(2) every 21 days. RESULTS: Febrile neutropenia was less common in the A-->T arm (29.3% of patients, 6.9% of cycles) compared with the AT arm (47.8% of patients, 14.8% of cycles; P =.02 and P =.0004, respectively). Asthenia, diarrhea, and fever occurred more frequently in the AT arm. The overall responses rates were 61% in the A-->T arm (95% CI, 50% to 72%) and 51% in the AT arm (95% CI, 39% to 63%). The median duration of response was 8.7 months (A-->T) and 7.6 months (AT); the median time to progression was 10.5 months (A-->T) and 9.2 months (AT); the median overall survival was 22.3 months (A-->T) and 21.8 months (AT); and no significant differences were found. CONCLUSION: A-->T significantly reduced febrile neutropenia compared with AT in MBC patients and maintains comparable antitumoral efficacy. A-->T represents a valid option for the treatment of MBC. 相似文献
68.
Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis 总被引:5,自引:0,他引:5
Joan Genesca M.D. Antonio Gonzalez M.D. Rosa Segura Ph.D. Robert Catalan M.D. Ramon Marti Ph.D. Encarna Varela M.D. Greg Cadelina Moises Martinez M.T Juan Carlos Lopez-Talavera M.D. Rafael Esteban M.D. Roberto J. Groszmann M.D. F.R.C.P. Jaime Guardia M.D. 《The American journal of gastroenterology》1999,94(1):169-177
Objective: Nitric oxide has been proposed as a mediator of hyperdynamic circulation in cirrhosis. Endotoxin and cytokines induce the synthesis of nitric oxide. The aim of this study was to investigate the relationship between endotoxemia, cytokines, and nitric oxide in patients with cirrhosis, and to correlate these findings with clinical, biochemical, and hemodynamic parameters. Methods: Clinical, biochemical, and hemodynamic parameters were assessed in 66 patients with cirrhosis and 15 controls. Levels of antidiuretic hormone, plasma renin activity, aldosterone, interferon γ, interleukin-1, interleukin-6, tumor necrosis factor α, endotoxin, and nitrates-nitrites were determined. Results: Mean arterial pressure was lower and interleukin-6, tumor necrosis factor α, nitrites-nitrates levels, and endotoxin positivity rates were higher in cirrhotics than in controls (p < 0.005). Mean arterial pressure decreased and interleukin-6 levels increased with worsening of Child score (p < 0.005). Patients with ascites had higher levels of interleukin-6, tumor necrosis factor α, and nitrates-nitrites than patients without ascites (p < 0.01). Elevated levels of interleukin-6 were found in patients with encephalopathy grade I, compared with patients without (p < 0.001); this association was independent of the severity of liver disease. In patients with low mean arterial pressure, interleukin-6 levels were higher than in patients with high mean arterial pressure (p = 0.001), whereas tumor necrosis factor α and nitrates-nitrites levels were not different. By multivariate analysis, high interleukin-6 levels showed independent associations with the presence of ascites, encephalopathy, and low mean arterial pressure. Only interleukin-6 levels had significant correlations with Child score, plasma renin activity, serum and urinary sodium, and mean arterial pressure (r ≥ 0.4, p < 0.005). Conclusions: Although the activity of the nitric oxide pathway is increased in patients with cirrhosis and might contribute to the hemodynamic alteration, other factors are involved. Interleukin-6, possibly through nitric oxide-independent mechanisms, also might play a role in the vasodilatation of cirrhosis and the pathogenesis of hepatic encephalopathy. 相似文献
69.
70.
Lucía López-Corral Luis Antonio Corchete María Eugenia Sarasquete María Victoria Mateos Ramón García-Sanz Encarna Fermi?án Juan-José Lahuerta Joan Bladé Albert Oriol Ana Isabel Teruel María Luz Martino José Hernández Jesús María Hernández-Rivas Francisco Javier Burguillo Jesús F. San Miguel Norma C. Gutiérrez 《Haematologica》2014,99(8):1365-1372